Cardinal Health CAH recently announced that it has entered into definitive agreements to acquire two companies. These agreements are likely to accelerate Cardinal Health's strategic growth areas ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other UBS’ top quant stocks in AI, IT, healthcare & other sectors. With the third quarter of ...

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition of ...

Michael Cherny has given his Buy rating due to a combination of factors that highlight Cardinal Health’s robust performance and positive outlook. The company began its fiscal year 2025 with ...

In a report released on November 1, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price target of $127.00. Erin Wright has given his ...

Cardinal Health expects that costs will increase for syringes and protective equipment like gloves under Biden administration tariffs, but broader tariffs under a potential Trump return would ...

Igor Golovniov / SOPA Images / LightRocket via Getty Images Cardinal Health beat first-quarter profit and sales estimates on growing demand by existing customers. Revenue fell at the healthcare ...

Leading medical distributors will be in focus on Friday after Cardinal Health (NYSE:CAH) reported better-than-expected financials for Q1 and raised its fiscal 2025 outlook, starting the group's ...

Use of Non-GAAP MeasuresThis earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In addition to ...

Cardinal Health's pharmaceutical and specialty solutions segment contributed to the company's strong performance in the first quarter, leading the Dublin, Ohio-based company to raise its fiscal ...

Friday, Cardinal Health Inc. (NYSE:CAH) reported first-quarter 2025 adjusted EPS of $1.88, up 9% year over year, beating the consensus of $1.62. Sales decreased 4% to $52.28 billion, beating the ...